Home | Simplified Chinese | Japanese | Korean
English About Changzhou Mayor’s Mailbox Government Bulletin Latest News Laws and Regulations
Construction starts on SPH Changzhou Pharma Business Center
Font:〖L M S

On the morning of March 18, a ground-breaking ceremony was held for the Business Center of SPH Changzhou Pharma. With a gross floor area of over 55,000 ㎡, the Center will have two high-rises and five annex buildings. It is designed to be a multi-functional industrial carrier, serving as office space, an R&D center, and an incubation accelerator. The Center, whose construction is due to be completed by December 2022, marks the largest single building project in the history of SPH Changzhou Pharma.

Headquartered in Shanghai, the Shanghai Pharmaceuticals Holding Co. Ltd. (SPH) is a vertically-integrated and diversified pharmaceutical group. In 2019, SPH reported revenues of US$26.5bn, ranking among Fortune Global 500 Companies. SPH is one of the few listed pharmaceutical companies with a leading position in both manufacturing and distribution in China. Changzhou Pharmaceuticals (Changzhou Pharma) is one of the core subsidiaries of SPH. With a history of 67 years, it provides leading health care services in R&D, manufacturing, distribution and retail.

扫一扫在手机打开当前页

 
Sponsored by: General Office and Foreign Affairs Office of Changzhou Municipal People’s Government All rights reserved
苏公网安备32041102000483号 网站标识码:3204000002 苏ICP备05003616号 Technical Support Phone:0519-85685023
Best viewed in IE 6.0 browser with and above 1024*768 resolution.